BMY
Bristol-Myers Squibb Co
3월 13일 4:00 PM ET (한국 3/14 05:00)
$59.08
+0.13 ▲ +0.22%
🌙 3월 13일 7:59 PM ET (한국 3/14 08:59)
$59.05
-0.03 ▼ -0.05%
| Index | S&P 500 | P/E | 17.08 | EPS (ttm) | 3.46 | Insider Own | 0.19% | Shs Outstand | 2.04B | Perf Week | -2.01% |
| Market Cap | 120.31B | Forward P/E | 9.66 | EPS next Y | -2.01% | Insider Trans | - | Shs Float | 2.03B | Perf Month | -1.42% |
| Enterprise Value | 156.81B | PEG | - | EPS next Q | 1.45 | Inst Own | 81.98% | Short Float | 1.64% | Perf Quarter | 15.37% |
| Income | 7.05B | P/S | 2.5 | EPS this Y | 1.53% | Inst Trans | 1.02% | Short Ratio | 2.43 | Perf Half Y | 24.27% |
| Sales | 48.19B | P/B | 6.51 | EPS next 5Y | -4.02% | ROA | 7.72% | Short Interest | 33.42M | Perf YTD | 9.53% |
| Book/sh | 9.07 | P/C | 11.27 | EPS past 3/5Y | 5.47% - | ROE | 40.53% | 52W High | -6.05% ($62.89) | Perf Year | -1.99% |
| Cash/sh | 5.24 | P/FCF | 9.37 | Sales past 3/5Y | 1.45% 2.54% | ROIC | 11.17% | 52W Low | 38.95% ($42.52) | Perf 3Y | -10.48% |
| Dividend Est. | $2.51 (4.26%) | EV/EBITDA | 8.15 | EPS Y/Y TTM | 178.35% | Gross Margin | 65.89% | Volatility(W/M) | 1.86% 1.98% | Perf 5Y | -2.57% |
| Dividend TTM | 2.49 | EV/Sales | 3.25 | Sales Y/Y TTM | -0.22% | Oper. Margin | 31.36% | ATR (14) | 1.33 | Perf 10Y | -9.05% |
| Dividend Ex-Date | 2026/4/2 | Quick Ratio | 1.14 | EPS Q/Q | -55.76% | Profit Margin | 14.64% | RSI (14) | 46.08 | Recom | 2.42 |
| Dividend Gr. 3/5Y | 4.37% 6.24% | Current Ratio | 1.26 | Sales Q/Q | 11.62% | SMA20 | -2.76% ($60.76) | Beta | 0.28 | Target Price | $62.04 |
| Payout | 71.98% | Debt/Eq | 2.55 | Earnings | 2000000 | SMA50 | 1.73% ($58.08) | Rel Volume | 0.68 | Prev Close | $58.95 |
| Employees | 32500 | LT Debt/Eq | 2.42 | EPS/Sales Surpr. | 2.77% 1.8% | SMA200 | 17.91% ($50.11) | Avg Volume(3M) | 13.78M | Price | $59.08 |
| IPO | 1929/7/5 | Option/Short | Yes/Yes | Trades | 59384 | Volume | 9,395,591 | Change | 0.22% |
뉴스 로딩 중...